berberine has been researched along with Weight Loss in 6 studies
Weight Loss: Decrease in existing BODY WEIGHT.
Excerpt | Relevance | Reference |
---|---|---|
"This study provides a critical overview of experimental studies in vitro, in humans, and in animals that evaluated the efficacy of Berberine and its effect on management of obesity and the related metabolic consequences." | 9.05 | The effect of Berberine on weight loss in order to prevent obesity: A systematic review. ( Al-Thawadi, S; Alalwan, TA; Gasparri, C; Ilyas, Z; Infantino, V; Perna, S; Peroni, G; Petrangolini, G; Riva, A; Rondanelli, M, 2020) |
"This study provides a critical overview of experimental studies in vitro, in humans, and in animals that evaluated the efficacy of Berberine and its effect on management of obesity and the related metabolic consequences." | 5.05 | The effect of Berberine on weight loss in order to prevent obesity: A systematic review. ( Al-Thawadi, S; Alalwan, TA; Gasparri, C; Ilyas, Z; Infantino, V; Perna, S; Peroni, G; Petrangolini, G; Riva, A; Rondanelli, M, 2020) |
"Berberine was administered through gavage to C57BL/6 mice with established CDI-induced intestinal injury and colitis." | 1.42 | Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment. ( Liu, W; Lv, Z; Peng, G; Su, J; Xu, H, 2015) |
"Berberine treatment resulted in increased AMP-activated protein kinase (AMPK) activity in 3T3-L1 adipocytes and L6 myotubes, increased GLUT4 translocation in L6 cells in a phosphatidylinositol 3' kinase-independent manner, and reduced lipid accumulation in 3T3-L1 adipocytes." | 1.33 | Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. ( Cho, HJ; Gosby, A; Hohnen-Behrens, C; James, DE; Kim, CT; Kim, JB; Kim, KH; Kim, WS; Kraegen, EW; Lee, CH; Lee, YS; Oh, WK; Shen, Y; Ye, JM; Yoon, MJ, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Amini, MR | 1 |
Sheikhhossein, F | 1 |
Naghshi, S | 1 |
Djafari, F | 1 |
Askari, M | 1 |
Shahinfar, H | 1 |
Safabakhsh, M | 1 |
Jafari, A | 1 |
Shab-Bidar, S | 1 |
Ilyas, Z | 1 |
Perna, S | 1 |
Al-Thawadi, S | 1 |
Alalwan, TA | 1 |
Riva, A | 1 |
Petrangolini, G | 1 |
Gasparri, C | 1 |
Infantino, V | 1 |
Peroni, G | 1 |
Rondanelli, M | 1 |
Lv, Z | 1 |
Peng, G | 1 |
Liu, W | 1 |
Xu, H | 1 |
Su, J | 1 |
Hu, Y | 1 |
Ehli, EA | 1 |
Kittelsrud, J | 1 |
Ronan, PJ | 1 |
Munger, K | 1 |
Downey, T | 1 |
Bohlen, K | 1 |
Callahan, L | 1 |
Munson, V | 1 |
Jahnke, M | 1 |
Marshall, LL | 1 |
Nelson, K | 1 |
Huizenga, P | 1 |
Hansen, R | 1 |
Soundy, TJ | 1 |
Davies, GE | 1 |
Lee, YS | 1 |
Kim, WS | 1 |
Kim, KH | 1 |
Yoon, MJ | 1 |
Cho, HJ | 1 |
Shen, Y | 1 |
Ye, JM | 1 |
Lee, CH | 1 |
Oh, WK | 1 |
Kim, CT | 1 |
Hohnen-Behrens, C | 1 |
Gosby, A | 1 |
Kraegen, EW | 1 |
James, DE | 1 |
Kim, JB | 1 |
Iizuka, N | 1 |
Hazama, S | 1 |
Yoshimura, K | 1 |
Yoshino, S | 1 |
Tangoku, A | 1 |
Miyamoto, K | 1 |
Okita, K | 1 |
Oka, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Therapeutic Effects of Combination of Insulin With Berberine on the Patients With Stess Hyperlipemia:a Prospective, Double Blind, Randomized, Placebo-controlled, Single-center Clinical Trial[NCT02806999] | Phase 4 | 200 participants (Anticipated) | Interventional | 2016-07-31 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for berberine and Weight Loss
Article | Year |
---|---|
Effects of berberine and barberry on anthropometric measures: A systematic review and meta-analysis of randomized controlled trials.
Topics: Anthropometry; Berberine; Berberis; Humans; Randomized Controlled Trials as Topic; Weight Loss | 2020 |
The effect of Berberine on weight loss in order to prevent obesity: A systematic review.
Topics: Adipocytes; Berberine; Blood Glucose; Cholesterol; Gastrointestinal Microbiome; Gluconeogenesis; Hum | 2020 |
1 trial available for berberine and Weight Loss
Article | Year |
---|---|
Lipid-lowering effect of berberine in human subjects and rats.
Topics: Adult; Animals; Berberine; Calcitriol; Cholesterol; Coptis; Drugs, Chinese Herbal; Female; Humans; H | 2012 |
3 other studies available for berberine and Weight Loss
Article | Year |
---|---|
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Base Sequence; Berberine; Clos | 2015 |
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states.
Topics: 3T3-L1 Cells; Adipocytes; Adipose Tissue; AMP-Activated Protein Kinases; Animals; Berberine; Cell Li | 2006 |
Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma.
Topics: Adenocarcinoma; Adipose Tissue; Animals; Berberine; Cachexia; Colonic Neoplasms; Coptis chinensis; D | 2002 |